Treating mitochondrial disorders requires full exploitation of available therapeutic options

Eitemau Tebyg

• Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()()
  gan: Finsterer, Josef, et al.
  Cyhoeddwyd: (2017)
• Letter to the Editor: Endocrine Compromise in Mitochondrial Disorders
  gan: Finsterer, Josef, et al.
  Cyhoeddwyd: (2018)
• MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders
  gan: Finsterer, Josef, et al.
  Cyhoeddwyd: (2018)
• Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
  gan: Finsterer, Josef, et al.
  Cyhoeddwyd: (2017)
• Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
  gan: Finsterer, Josef, et al.
  Cyhoeddwyd: (2017)